Currently viewing: Consolidated statement of profit or loss / Next: Consolidated statement of comprehensive income

Consolidated statement of profit or loss

for the year ended 30 September 2021

Notes  2021 
R'm
 
20201
R'm 
Continuing operations 
Revenue  2  26 885  23 851 
Other income  2  253  185 
Drugs and consumables  (6 093) (5 194)
Employee benefits expense  3  (9 424) (8 707)
Retirement benefit asset and post-employment medical aid income  33  32 
Depreciation on property, plant and equipment  (1 571) (1 476)
Amortisation of intangible assets  (533) (590)
Repairs and maintenance expenditure on property, plant and equipment  (776) (657)
Occupational expenses  (883) (832)
Hospital service expenses  (772) (712)
Communication expenses  (419) (382)
Radiology service costs  (1 673) (1 405)
Professional, legal and secretarial fees  (498) (493)
Provision for expected credit losses  (116) (171)
Other expenses  6  (1 433) (1 328)
Operating profit before items below  2 980  2 121 
Fair value gain/(loss) on financial instruments  4  32  (5)
Gain on derecognition of lease asset and liability  –  75 
Impairment of assets and investments  11, 12  (14) (5)
Profit on remeasuring previously held interest in associate to fair value  27  28  - 
Loss on disposal of property, plant and equipment  (17) (6)
Transaction costs relating to acquisitions and disposals  (3) (8)
Finance income  5  169  85 
Finance cost  5  (791) (878)
Share of associates' and joint ventures' net profit after tax  12  25  14 
Profit before tax  6  2 409  1 393 
Tax expense  7  (642) (556)
Profit after tax from continuing operations  1 767  837 
Discontinued operation 
Profit/(loss) from discontinued operation  27  87  (799)
Profit after tax  1 854  38 
Profit after tax attributable to: 
Ordinary equity holders of the parent  1 754  (93)
Non-controlling interest  100  131 
1 854  38 
Earnings/(loss) per share (cents)
From continuing operations 
    Basic  8  114.6  48.5 
    Diluted  8  114.3  48.4 
From continuing and discontinued operations 
    Basic  8  120.6  (6.4)
    Diluted  8  120.3  (6.4)
1 Prior period re-presented. Scanmed S.A. (Scanmed) was disposed of on 26 March 2021 and is included under discontinued operation. Refer note 27.

The accompanying notes are an integral part of these consolidated financial statements.